"The new injection should cut that procedure to just a couple of minutes, saving patients and staff valuable time. Shirley Xerxes, an 86-year-old patient, noted, 'It's made such a difference and gives me more time to live my life, including spending more time gardening.'"
"About 14,000 cancer patients in England start on a course of Keytruda each year, with most likely to be moved over to the injectable version. The drug can currently be used to treat 14 different types of cancer in the UK."
"Immunotherapy works by blocking the signal allowing those cancer cells to be more easily recognised and destroyed. Keytruda was one of the earliest immunotherapy drugs to be approved, first for skin cancer and later for other forms of the disease."
Keytruda, an immunotherapy drug for cancer treatment, is now available in an injectable form that reduces administration time from over an hour to just a couple of minutes. This change is expected to benefit around 14,000 patients in England annually. The injectable version can be administered every three weeks or every six weeks, depending on the cancer type. Keytruda treats 14 different cancers, enhancing the immune system's ability to attack cancer cells by blocking signals that allow them to evade detection.
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]